As per the market analysis at PMR, the microelectronic medical implants market is valued at US$ 43.4 Billion in 2022 and is likely to reach US$ 98.5 billion by 2032, thriving at a promising CAGR of 8.5%.

The increasing number of epilepsy cases, cardiac disorders and Parkinson's disease coupled with growing geriatric population and compliances for new medium, devices and launch of new products are pushing the sales of microelectronic medical implants.

The increasing cases of cardiovascular disorders and epilepsy along with cardiac arrest and congestive heart failure and strokes are driving the sales of microelectronic medical implants. The implants involve pacemakers and defibrillators, with new-gen technology, helping cardiac patients.

With the new sensor technology coming through in the market, integrating with the latest platforms like machine learning and AI are pushing the healthcare industry to adopt implants, fueling the demand for microelectronic medical implants.